Drug class
Tetracyclic antidepressant; selective and reversible monoamine oxidase A (MAO-A) inhibitor
Mechanism of action
Selectively and reversibly inhibits monoamine oxidase A, reducing metabolism of serotonin and noradrenaline. It also has secondary inhibitory effects on neuronal reuptake of these monoamines.
General use cases
- Treatment of depressive disorders in countries where pirlindole remains authorised; it is not a generally marketed antidepressant in all jurisdictions.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
